Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysis.
Saved in:
| Title: | Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysis. |
|---|---|
| Authors: | Boot AM; Department of Pediatric Endocrinology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, Groningen 9713 GZ, The Netherlands., Ariceta G; Department of Pediatric Nephrology, University Hospital Vall d'Hebron, Autonomous University of Barcelona, Barcelona, Spain., Beck-Nielsen SS; Centre for Rare Diseases, Pediatric Department, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Brandi ML; FIRMO Foundation, Florence, Italy., Briot K; AP-HP, Department of Rheumatology, Cochin Hospital, Paris, France., Collantes CL; Pediatric Nephrology, Hospital Infantil Universitario Niño Jesús, Universidad Autónoma de Madrid, Madrid, Spain., Giannini S; Department of Medicine, Clinica Medica 1, University of Padova, Padova, Italy., Haffner D; Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, Hannover, Germany., Keen R; Royal National Orthopaedic Hospital, Stanmore, UK., Levtchenko E; Department of Pediatric Nephrology, Amsterdam University Medical Centre, Amsterdam, The Netherlands., Mughal MZ; Department of Pediatric Endocrinology, Royal Manchester Children's Hospital, Manchester, UK.; Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Mäkitie O; Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Nilsson O; Division of Pediatric Endocrinology, Center for Molecular Medicine, Department of Women's and Children's Health, Karolinska Institutet and University Hospital, Stockholm, Sweden.; Department of Pediatrics and School of Medical Sciences, Örebro University and University Hospital, Örebro, Sweden., Schnabel D; Center for Chronically Sick Children, Pediatric Endocrinology, Charitè, University Medicine, Berlin, Germany., Tripto-Shkolnik L; The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Division of Endocrinology, Diabetes and Metabolism, Sheba Medical Center, Tel HaShomer, Israel., Zillikens MC; Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Liu J; Kyowa Kirin International, Marlow, UK., Tudor A; Kyowa Kirin International, Marlow, UK., Emma F; Division of Nephrology, Bambino Gesù Children's Hospital IRCCS, Rome, Italy. |
| Source: | Therapeutic advances in chronic disease [Ther Adv Chronic Dis] 2024 May 18; Vol. 15, pp. 20406223241247643. Date of Electronic Publication: 2024 May 18 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: SAGE Publications Country of Publication: United States NLM ID: 101532140 Publication Model: eCollection Cited Medium: Print ISSN: 2040-6223 (Print) Linking ISSN: 20406223 NLM ISO Abbreviation: Ther Adv Chronic Dis Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38764445 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Boot+AM%22">Boot AM</searchLink>; Department of Pediatric Endocrinology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, Groningen 9713 GZ, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Ariceta+G%22">Ariceta G</searchLink>; Department of Pediatric Nephrology, University Hospital Vall d'Hebron, Autonomous University of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Beck-Nielsen+SS%22">Beck-Nielsen SS</searchLink>; Centre for Rare Diseases, Pediatric Department, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.<br /><searchLink fieldCode="AU" term="%22Brandi+ML%22">Brandi ML</searchLink>; FIRMO Foundation, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Briot+K%22">Briot K</searchLink>; AP-HP, Department of Rheumatology, Cochin Hospital, Paris, France.<br /><searchLink fieldCode="AU" term="%22Collantes+CL%22">Collantes CL</searchLink>; Pediatric Nephrology, Hospital Infantil Universitario Niño Jesús, Universidad Autónoma de Madrid, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Giannini+S%22">Giannini S</searchLink>; Department of Medicine, Clinica Medica 1, University of Padova, Padova, Italy.<br /><searchLink fieldCode="AU" term="%22Haffner+D%22">Haffner D</searchLink>; Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22Keen+R%22">Keen R</searchLink>; Royal National Orthopaedic Hospital, Stanmore, UK.<br /><searchLink fieldCode="AU" term="%22Levtchenko+E%22">Levtchenko E</searchLink>; Department of Pediatric Nephrology, Amsterdam University Medical Centre, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Mughal+MZ%22">Mughal MZ</searchLink>; Department of Pediatric Endocrinology, Royal Manchester Children's Hospital, Manchester, UK.; Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Mäkitie+O%22">Mäkitie O</searchLink>; Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Nilsson+O%22">Nilsson O</searchLink>; Division of Pediatric Endocrinology, Center for Molecular Medicine, Department of Women's and Children's Health, Karolinska Institutet and University Hospital, Stockholm, Sweden.; Department of Pediatrics and School of Medical Sciences, Örebro University and University Hospital, Örebro, Sweden.<br /><searchLink fieldCode="AU" term="%22Schnabel+D%22">Schnabel D</searchLink>; Center for Chronically Sick Children, Pediatric Endocrinology, Charitè, University Medicine, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Tripto-Shkolnik+L%22">Tripto-Shkolnik L</searchLink>; The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Division of Endocrinology, Diabetes and Metabolism, Sheba Medical Center, Tel HaShomer, Israel.<br /><searchLink fieldCode="AU" term="%22Zillikens+MC%22">Zillikens MC</searchLink>; Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Liu+J%22">Liu J</searchLink>; Kyowa Kirin International, Marlow, UK.<br /><searchLink fieldCode="AU" term="%22Tudor+A%22">Tudor A</searchLink>; Kyowa Kirin International, Marlow, UK.<br /><searchLink fieldCode="AU" term="%22Emma+F%22">Emma F</searchLink>; Division of Nephrology, Bambino Gesù Children's Hospital IRCCS, Rome, Italy. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101532140%22">Therapeutic advances in chronic disease</searchLink> [Ther Adv Chronic Dis] 2024 May 18; Vol. 15, pp. 20406223241247643. <i>Date of Electronic Publication: </i>2024 May 18 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22SAGE+Publications%22">SAGE Publications </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101532140 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2040-6223 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220406223%22">20406223 </searchLink><i>NLM ISO Abbreviation: </i>Ther Adv Chronic Dis <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38764445 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1177/20406223241247643 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 20406223241247643 Titles: – TitleFull: Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Boot AM – PersonEntity: Name: NameFull: Ariceta G – PersonEntity: Name: NameFull: Beck-Nielsen SS – PersonEntity: Name: NameFull: Brandi ML – PersonEntity: Name: NameFull: Briot K – PersonEntity: Name: NameFull: Collantes CL – PersonEntity: Name: NameFull: Giannini S – PersonEntity: Name: NameFull: Haffner D – PersonEntity: Name: NameFull: Keen R – PersonEntity: Name: NameFull: Levtchenko E – PersonEntity: Name: NameFull: Mughal MZ – PersonEntity: Name: NameFull: Mäkitie O – PersonEntity: Name: NameFull: Nilsson O – PersonEntity: Name: NameFull: Schnabel D – PersonEntity: Name: NameFull: Tripto-Shkolnik L – PersonEntity: Name: NameFull: Zillikens MC – PersonEntity: Name: NameFull: Liu J – PersonEntity: Name: NameFull: Tudor A – PersonEntity: Name: NameFull: Emma F IsPartOfRelationships: – BibEntity: Dates: – D: 18 M: 05 Text: 2024 May 18 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 2040-6223 Numbering: – Type: volume Value: 15 Titles: – TitleFull: Therapeutic advances in chronic disease Type: main |
| ResultId | 1 |
